Daily drinking decisions: study tests if skipping booze stops AFib Flare-Ups

NCT ID NCT06754176

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether avoiding alcohol reduces the chance of an atrial fibrillation (AFib) episode in people with paroxysmal AFib. One hundred participants will be randomly assigned each day to either avoid or be allowed to drink alcohol. They will wear heart monitors, fitness trackers, alcohol sensors, and glucose monitors for two weeks. The goal is to see if AFib episodes happen more often on drinking days versus non-drinking days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral intervention: daily instructions to avoid or not avoid alcohol
What this could lead to
If it works, this could help people with paroxysmal AFib understand whether skipping alcohol reduces their risk of an episode.
What could go wrong
This is a small, short-term study (100 people, 2 weeks) looking at immediate effects only. Results may not apply to all AFib patients or predict long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UCSF Medical Center at Mission Bay

    RECRUITING

    San Francisco, California, 94158, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • UCSF Medical Center at Parnassus

    RECRUITING

    San Francisco, California, 94143, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.